0000950129-05-000834.txt : 20120703
0000950129-05-000834.hdr.sgml : 20120703
20050202152507
ACCESSION NUMBER: 0000950129-05-000834
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050202
DATE AS OF CHANGE: 20050202
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: ZIERING MARILYN
CENTRAL INDEX KEY: 0001002106
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
BUSINESS PHONE: 2137760180
MAIL ADDRESS:
STREET 1: 5700 W 96TH STREET
STREET 2: C/O DIAGNOSTIC PRODUCTS CORP
CITY: LOS ANGELES
STATE: CA
ZIP: 90045
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: DIAGNOSTIC PRODUCTS CORP
CENTRAL INDEX KEY: 0000702259
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 952802182
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-34645
FILM NUMBER: 05569213
BUSINESS ADDRESS:
STREET 1: 5210 PACIFIC CONCOURSE DRIVE
CITY: LOS ANGELES
STATE: CA
ZIP: 90045
BUSINESS PHONE: 3106458200
MAIL ADDRESS:
STREET 1: 5210 PACIFIC CONCOURSE DRIVE
CITY: LOS ANGELES
STATE: CA
ZIP: 90045
SC 13G/A
1
v05011sc13gza.txt
SCHEDULE 13G/AMENDMENT NO. 20
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 20)
DIAGNOSTIC PRODUCTS CORPORATION
-------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, NO PAR VALUE
--------------------------------------------------------
(Title of Class of Securities)
252450-10-1
------------------------------------------
(CUSIP Number)
DECEMBER 31, 2004
-----------------------------------------
(Date of Event which Requires Filing This Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed.
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[x] Rule 13d-1(d)
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP NO. 252450-10-1
1. NAME OF REPORTING PERSON
MARILYN ZIERING
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP.
(A) [ ]
(B) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
NUMBER OF 5. SOLE VOTING POWER: 4,771,834
SHARES
BENEFICIALLY 6. SHARED VOTING POWER: -0-
OWNED BY
EACH REPORTING 7. SOLE DISPOSITIVE POWER: 4,771,834
PERSON WITH
8. SHARED DISPOSITIVE POWER: -0-
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,771,834
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.
16.3%
12. TYPE OF REPORTING PERSON
IN
Item 1(a) Name of Issuer: Diagnostic Products Corporation
--------------
Item 1(b) Address of Issuer's Principal Executive Offices:
-----------------------------------------------
5210 Pacific Concourse Drive
Los Angeles, California 90045
Item 2(a) Name of Person Filing: Marilyn Ziering
Item 2(b) Address of Principal Business Office: 5210 Pacific Concourse Drive
------------------------------------ Los Angeles, CA 90045
Item 2(c) Citizenship: U.S.A.
-----------
Item 2(d) Title of Class of Securities: Common Stock
----------------------------
Item 2(e) CUSIP Number: 252450-10-1
------------
Item 3 Statement filed Pursuant to Rules 13d-1(b) or 13(d)-2(b) or (c):
---------------------------------------------------------------
Not Applicable
Item 4(a) Amount Beneficially Owned: 4,771,834 shares.
-------------------------
Item 4(b) Percent of Class: 16.3%.
----------------
Item 4(c) For information regarding the number of shares as to which the
reporting person has voting and dispositive power, see Items 5-8 of
page 2.
Item 5 Ownership of 5% or Less of Class: Not Applicable
--------------------------------
Item 6 Ownership of More than 5% on Behalf of Another Person:
-----------------------------------------------------
Not Applicable
Item 7 Identification and Classification of the Subsidiary which Acquired
the Security Being Reported on by the Parent Holding Company:
------------------------------------------------------------
Not Applicable
Item 8 Identification and Classification of Members of the Group:
---------------------------------------------------------
Not applicable.
Item 9 Notice of Dissolution of Group: Not Applicable
------------------------------
Item 10 Certification: Not Applicable
-------------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 2, 2005 /S/ Marilyn Ziering
------------------------------
Marilyn Ziering